This website is intended for healthcare professionals only

Trending Topic

Close-up of a person rubbing their temple, depicting persistent headache pain
13 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Migraines profoundly impact well-being, especially in children and adolescents. From 1990 to 2021, global pediatric migraine disability has increased, with particular vulnerability in females and adolescents aged 15–19.1 A 2023 meta-analysis found the prevalence of primary headache diagnosis in individuals aged 8–18 years to be 62%.2 The prevalence of a migraine diagnosis was 11%; 8% […]

Neurostimulation & Patients UK Experience

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Dec 15th 2015

Dr. Simon Thomson, MBBS, FRCA, FIPP, International Neuromodulation Society (INS) president from 2009 – June 2015 is a consultant in neuromodulation and pain management at Basildon and Thurrock University NHS Trust, as well as serving on the staff of Addenbrookes Hospital, Cambridge. He presented a talk about the National Institute for Health and Care Excellence (NICE) technology assessment for spinal cord stimulation in England and Wales. The assessment concluded that spinal cord stimulation for neuropathic pain is clinically effective at an achievable cost, making it mandatory for all health bodies to commission it appropriately due to its demonstrated cost-effectiveness.

Disclaimer: The International Neuromodulation Society (INS) provides videotaped talks by physicians and patients about neuromodulation therapy on its YouTube channel. INS produced videos of talks presented at a public event in 2015 that was jointly organized by the INS and the Canadian Neuromodulation Society. The information presented should not be used as a substitute for medical treatment and advice.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup